Table 5.
Traits | EC121 | J53 | C600 | ACG04 | ACC09 |
---|---|---|---|---|---|
Antimicrobial a | |||||
ceftazidime | 64 | 0.25 | 0.25 | 8 | 2 |
ceftriaxone | ≥64 | ≤0.125 | ≤0.125 | >64 | >64 |
cefepime | 16 | 0.25 | ≤0.125 | 16 | 2 |
piperacillin/tazobactam | >256 | 2 | 2 | 8 | 2 |
aztreonam | >32 | ≤0.125 | ≤0.125 | 16 | 4 |
amikacin | 4 | 2 | 2 | 16 | 2 |
gentamycin | 16 | 0.5 | 0.5 | 32 | 0.5 |
trimethoprim/sulfamethoxazole | >128 | ≤0.25 | ≤0.25 | >128 | >128 |
ciprofloxacin | >64 | ≤0.125 | ≤0.125 | ≤0.125 | ≤0.125 |
minocycline | 16 | 1 | 1 | 4 | 1 |
tigecycline | 1 | 0.25 | 0.125 | 0.25 | 0.125 |
Replicon type b | |||||
IncHI2 | + | - | - | + | + |
IncL/M | + | - | - | + | - |
IncFIB | + | - | - | + | - |
IncN | + | - | - | + | - |
Virulence c | |||||
hlyF | + | - | - | + | - |
iroN | + | - | - | + | - |
sitA | + | - | - | + | - |
Resistance gene | |||||
bla CTX-M | + | - | - | + | + |
a The antimicrobial resistance phenotype of transconjugant strains was assessed by minimum inhibitory concentration (MIC), performed using the broth microdilution method according to EUCAST guideline, and expressed in µg/mL. Bold values indicate an increased MIC value when comparing strains bearing plasmids with its receptor strain which is devoid of plasmids; b replicons identified in EC121 by PlasmidFinder, and screened by PCR; c virulence genes identified in EC121 genome and screened by PCR; + for the presence of the gene; - for the absence of the gene.